US Patent Issued to PHAROS IBIO on July 21 for "Use of 2,3,5-substituted thiophene compound for enhancement of radiotherapy" (South Korean Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,729, issued on July 21, was assigned to PHAROS IBIO Co. LTD. (Gyeonggi-Do, South Korea).

"Use of 2,3,5-substituted thiophene compound for enhancement of radiotherapy" was invented by Jeong Hyeok Yoon (Yongin-Si, South Korea) and Ky Youb Nam (Goyang-Si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a composition for enhancing radiotherapy, the composition containing a 2,3,5-substituted thiophene compound of Formula 1 or a pharmaceutically acceptable salt thereof. The composition may increase the sensitivity of cancer cells to radiation, and thus may be advantageously used to enhance the effect of radioth...